TW201014856A - N-sulfonamido polycyclic pyrazolyl compounds - Google Patents

N-sulfonamido polycyclic pyrazolyl compounds Download PDF

Info

Publication number
TW201014856A
TW201014856A TW098129931A TW98129931A TW201014856A TW 201014856 A TW201014856 A TW 201014856A TW 098129931 A TW098129931 A TW 098129931A TW 98129931 A TW98129931 A TW 98129931A TW 201014856 A TW201014856 A TW 201014856A
Authority
TW
Taiwan
Prior art keywords
group
alkyl
phenyl
trifluoromethyl
alkoxy
Prior art date
Application number
TW098129931A
Other languages
English (en)
Chinese (zh)
Inventor
Andrei W Konradi
Xiaocong Michael Ye
Simeon Bowers
Albert W Garofalo
Danielle L Aubele
Darren Dressen
Raymond Ng
Gary Probst
Christopher M Semko
Minghua Sun
Anh P Truong
Michael S Dappen
Original Assignee
Elan Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc filed Critical Elan Pharm Inc
Publication of TW201014856A publication Critical patent/TW201014856A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/18—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW098129931A 2008-09-05 2009-09-04 N-sulfonamido polycyclic pyrazolyl compounds TW201014856A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9479908P 2008-09-05 2008-09-05
US9924108P 2008-09-23 2008-09-23
US17327809P 2009-04-28 2009-04-28
US22653209P 2009-07-17 2009-07-17

Publications (1)

Publication Number Publication Date
TW201014856A true TW201014856A (en) 2010-04-16

Family

ID=41258775

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098129931A TW201014856A (en) 2008-09-05 2009-09-04 N-sulfonamido polycyclic pyrazolyl compounds

Country Status (20)

Country Link
US (1) US8283358B2 (cg-RX-API-DMAC7.html)
EP (1) EP2346863A2 (cg-RX-API-DMAC7.html)
JP (1) JP2012502051A (cg-RX-API-DMAC7.html)
KR (1) KR20110055715A (cg-RX-API-DMAC7.html)
CN (1) CN102203089A (cg-RX-API-DMAC7.html)
AR (1) AR073497A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009289579A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0918213A2 (cg-RX-API-DMAC7.html)
CA (1) CA2736767A1 (cg-RX-API-DMAC7.html)
CL (1) CL2011000405A1 (cg-RX-API-DMAC7.html)
CO (1) CO6362008A2 (cg-RX-API-DMAC7.html)
EA (1) EA201170421A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP11010947A (cg-RX-API-DMAC7.html)
IL (1) IL211263A0 (cg-RX-API-DMAC7.html)
MA (1) MA32688B1 (cg-RX-API-DMAC7.html)
MX (1) MX2011002047A (cg-RX-API-DMAC7.html)
PE (1) PE20110418A1 (cg-RX-API-DMAC7.html)
TW (1) TW201014856A (cg-RX-API-DMAC7.html)
WO (1) WO2010028213A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201101994B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009289649B2 (en) 2008-09-03 2016-05-05 Biomarin Pharmaceutical Inc. Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
US8283358B2 (en) 2008-09-05 2012-10-09 Elan Pharmaceuticals, Inc. N-sulfonamido polycyclic pyrazolyl compounds
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
WO2012118782A1 (en) 2011-02-28 2012-09-07 Repligen Corporation Histone deacetylase inhibitors
RU2665554C2 (ru) 2013-03-15 2018-08-31 Байомарин Фармасьютикал Инк. Ингибиторы hdac
EP4084797A4 (en) * 2020-01-03 2024-02-21 Blue Oak Pharmaceuticals, Inc. COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISEASES
CN111909217B (zh) * 2020-08-20 2023-05-02 昆明贵金属研究所 一种双(二叔丁基-4-二甲氨基苯基膦)四溴双钯(ⅱ)化合物及其制备方法和用途
CN115448892B (zh) * 2022-09-19 2023-07-07 郑州铁路职业技术学院 一种苯并噻二唑杂环化合物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727989D0 (en) * 1987-11-30 1988-01-06 Merck Sharp & Dohme Therapeutic agents
EP0330788A1 (en) 1988-03-01 1989-09-06 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
WO2005113542A2 (en) 2004-05-20 2005-12-01 Elan Pharmaceuticals, Inc. N-cyclic sulfonamido inhibitors of gamma secretase
JP2009504773A (ja) * 2005-08-19 2009-02-05 エラン ファーマシューティカルズ,インコーポレイテッド ガンマセクレターゼの架橋n−二環式スルホンアミド阻害剤
TW200813054A (en) 2006-06-02 2008-03-16 Elan Pharm Inc Fused, tricyclic sulfonamide inhibitors of gamma secretase
CN101128035B (zh) 2006-08-18 2011-08-24 中兴通讯股份有限公司 时分码分多址系统中信道间的定时方法
MX2009012525A (es) * 2007-05-25 2009-12-09 Elan Pharm Inc Pirazol-pirrolidinas como inhibidores de gamma secretasa.
US8283358B2 (en) 2008-09-05 2012-10-09 Elan Pharmaceuticals, Inc. N-sulfonamido polycyclic pyrazolyl compounds

Also Published As

Publication number Publication date
EP2346863A2 (en) 2011-07-27
IL211263A0 (en) 2011-04-28
US20100081680A1 (en) 2010-04-01
KR20110055715A (ko) 2011-05-25
EA201170421A1 (ru) 2012-01-30
ECSP11010947A (es) 2011-07-29
BRPI0918213A2 (pt) 2015-12-08
CO6362008A2 (es) 2012-01-20
MX2011002047A (es) 2011-06-17
AU2009289579A1 (en) 2010-03-11
AR073497A1 (es) 2010-11-10
WO2010028213A2 (en) 2010-03-11
US8283358B2 (en) 2012-10-09
PE20110418A1 (es) 2011-06-22
ZA201101994B (en) 2011-11-30
CN102203089A (zh) 2011-09-28
CL2011000405A1 (es) 2011-07-01
MA32688B1 (fr) 2011-10-02
WO2010028213A3 (en) 2010-06-03
CA2736767A1 (en) 2010-03-11
JP2012502051A (ja) 2012-01-26

Similar Documents

Publication Publication Date Title
JP5485346B2 (ja) アリール置換およびヘテロアリール置換テトラヒドロベンズアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用
TW200916469A (en) Multi-cyclic compounds
TW200909429A (en) Gamma secretase modulators
KR20170005861A (ko) 항당뇨병 트리시클릭 화합물
TW201219400A (en) Compounds for treating neurodegenerative diseases
CN102333777A (zh) 含氮的稠合杂环化合物及其作为β淀粉样蛋白生成抑制剂的用途
TW200409771A (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
TW201043625A (en) Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
TW200813054A (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase
TW201000478A (en) Pyrido[3,4-b]indoles and methods of use
TW201217381A (en) Imidazotriazinone compounds
TW201018694A (en) Indole and indoline derivatives and methods of use thereof
TW200948364A (en) Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
US6150376A (en) Bi- and tri-cyclic aza compounds and their uses
KR102171710B1 (ko) 감마 세크레타제 조절 인자로서의 신규 치환 피리도-피페라지논 유도체
US8283358B2 (en) N-sulfonamido polycyclic pyrazolyl compounds
TW201144323A (en) Amino-oxazines and amino-dihydrothiazine compounds as Beta-secretase modulators and methods of use
TW201034666A (en) Gamma secretase modulators
TW200904413A (en) Pyrazolopyrrolidines as inhibitors of gamma secretase
JP6033085B2 (ja) 三環式誘導体ならびにそれらの医薬用途および組成物
CN115667273A (zh) 毒蕈碱型乙酰胆碱受体m5的竞争性和非竞争性抑制剂
JP5873612B2 (ja) 三環式誘導体ならびにそれらの医薬用途および組成物
JPH08502293A (ja) 認識疾患の治療に有用な3,3−ジ置換された三環式および四環式インドリン−2−オン
HK40030367B (en) 1, 3, 4, 5-tetrahydro-2h-pyrido[4,3-b]indole derivatives for the treatment, alleviation or prevention of disorders associated with tau aggregates like alzheimer&#39;s disease
HK1132270A (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase